26 - Meeting Resistance: Novel Methods for Antimicrobial Resistance

Thursday, October 17, 2024

10:30 AM – 11:45 AM US PT

Location: 502 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Patricia Simner, PhD

Associate Professor, Director of Bacteriology
Johns Hopkins School of Medicine
Baltimore, MD, United States
Lars Westblade, PhD

Clinical Microbiology Laboratory Director/Associate Professor
Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY, United States

Faculty(s)

Kimberly Hanson, MD, MHS

Professor
Medicine and Pathology
University of Utah
Salt Lake City, UT, United States
Amir Semouydsavi, VMD. PhD. FECMM (he/him/his)

Clinical Microbiology Senior Staff, Director of Mycology and Parasitology Diagnostics
National Institutes of Health, Clinical Center, MD, United States
Lars Westblade, PhD

Clinical Microbiology Laboratory Director/Associate Professor
Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY, United States

Disclosure(s):

Patricia J. Simner, PhD: Affinity Biosensors: Grant/Research Support; BD Diagnostics: Grant/Research Support; bioMérieux: Grant/Research Support; Entasis: Personal fees; GeneCapture: Personal Fees; Merck: Personal fees; OpGen Inc: Grant/Research Support; Qiagen: Grant/Research Support; Shionogi: Personal fees; T2 Biosystems: Grant/Research Support

Lars Westblade, PhD: Accelerate Diagnostics, Inc: Grant/Research Support (); bioMerieux, Inc: Grant/Research Support (); Element Materials Technology: Grant/Research Support (); Hardy Diagnostics: Grant/Research Support (); Roche Molecular Systems, Inc.: Advisor/Consultant (), Grant/Research Support (); Selux Diagnostics, Inc.: Grant/Research Support (); Shionogi, Inc: Advisor/Consultant (); Talis Biomedical: Advisor/Consultant ()

Kimberly Hanson, MD, MHS: Health Tracks: Advisor/Consultant (Ongoing); Karius: Advisor/Consultant (Ongoing)

Amir Semouydsavi, VMD. PhD. FECMM: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the current landscape and diagnostic challenges that we face with the rise in antimicrobial resistance;
explain novel diagnostic methods to detect antimicrobial resistance among viral, bacterial and fungal pathogens;
identify how novel methods for detection of antimicrobial resistant pathogens can be applied to guide patient management.

Presentations:

10:30 AM – 10:55 AM US PT

Viral AMR Detection
Speaker: Kimberly Hanson, MD, MHS – University of Utah
10:55 AM – 11:20 AM US PT

Fungal AMR Detection
Speaker: Amir Semouydsavi, VMD. PhD. FECMM (he/him/his) – National Institutes of Health, Clinical Center
11:20 AM – 11:45 AM US PT

Bacterial AMR Detection
Speaker: Lars Westblade, PhD – Weill Cornell Medicine